Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy.

@article{Francia2017PrognosticIO,
  title={Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy.},
  author={Pietro Francia and Carmen Adduci and Lorenzo Semprini and Francesca Palano and Daria Santini and Beatrice Musumeci and Caterina Santolamazza and Massimo Volpe and Camillo Autore},
  journal={Journal of cardiovascular electrophysiology},
  year={2017},
  volume={28 1},
  pages={
          103-108
        }
}
INTRODUCTION In hypertrophic cardiomyopathy (HCM) patients the need for defibrillation threshold (DFT) testing at the time of ICD implantation is debated. Moreover, its prognostic implications have never been explored. In a cohort of HCM patients we sought to (a) investigate factors prompting DFT testing, (b) evaluate ICD efficacy by testing DFT, (c) compare DFT in patients with and without massive LVH, and (d) assess whether DFT testing predicts shock efficacy for spontaneous VT/VF. METHODS… CONTINUE READING